SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-039902
Filing Date
2022-11-04
Accepted
2022-11-03 19:01:04
Documents
16
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10043738_8k.htm   iXBRL 8-K 29265
2 EXHIBIT 99.1 brhc10043738_ex99-1.htm EX-99.1 236968
3 EXHIBIT 99.2 brhc10043738_ex99-2.htm EX-99.2 26668
7 image0.jpg GRAPHIC 32875
8 image00001.jpg GRAPHIC 3425
  Complete submission text file 0001140361-22-039902.txt   544147

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cemi-20221103.xsd EX-101.SCH 3863
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20221103_lab.xml EX-101.LAB 22547
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20221103_pre.xml EX-101.PRE 16043
10 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043738_8k_htm.xml XML 4056
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 221359714
SIC: 2834 Pharmaceutical Preparations